John Johnson Buys Shares of Axogen, Inc.
John Johnson acquired 14,150 shares of Axogen, Inc. on June 19, 2026.
Key Points
- John Johnson purchased 14,150 shares of Axogen, Inc. on June 19, 2026; the transaction was not planned.
- Axogen, Inc. shares traded at $44.95 on Wednesday, with a market cap of $2.39 billion and a forward P/E of 61.7.
- Analysts from Canaccord Genuity and Citizens maintain a 'buy' rating with a price target of $50.
Important disclosure: EarningsIQ is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
John Johnson recently acquired 14,150 shares of Axogen, Inc. (NasdaqCM: AXGN) on June 19, 2026. This insider purchase was not part of a pre-planned trading program.
Other Institutional Activity in Axogen, Inc.
Several institutional investors have been active in Axogen, Inc. FIRST LIGHT ASSET MANAGEMENT, LLC reduced its holdings by 1,230,558 shares, ending with 4,002,768 shares valued at approximately $132.6 million, a 23.5% decrease. BLACKROCK, INC. added 151,414 shares, bringing its total to 3,870,851 shares worth about $128.2 million, marking a 4.1% increase. MORGAN STANLEY increased its stake by 536,112 shares, resulting in 3,122,982 shares valued at $103.5 million, a 20.7% rise. VANGUARD CAPITAL MANAGEMENT LLC opened a new position with 2,291,563 shares valued at nearly $75.9 million. ARROWMARK COLORADO HOLDINGS LLC boosted its holdings by 441,157 shares, ending with 1,915,439 shares valued at $63.5 million, a 29.9% increase.
Axogen, Inc. Stock Up 0.2%
Shares of Axogen, Inc. traded near $44.95 on Wednesday. The company holds a market cap of approximately $2.39 billion. With a forward P/E ratio of 61.7 and a beta of 1.118, the stock has seen a 52-week low of $9.35 and a high of $45.83. The 50-day moving average stands at $40.43, while the 200-day moving average is $30.40. Axogen maintains a strong financial position with a current ratio of 7.1 and a quick ratio of 5.0.
$AXGN stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
Axogen, Inc. reported revenue of $238.1 million, showing a growth of 26.6% over the previous year. Despite this growth, the company has a negative net margin of 13.2% and a return on equity of -17.96%. The next earnings report is expected on August 4, 2026.
Analysts Set New Price Targets
On April 29, 2026, Canaccord Genuity and Citizens both maintained their 'buy' ratings for Axogen, Inc., with price targets set at $50. Wells Fargo also maintained a 'buy' rating with a target of $48. The consensus among nine analysts suggests a mean price target of $50.78.
About Axogen, Inc.
Axogen, Inc., based in Alachua, Florida, operates in the healthcare sector, specifically within the medical devices industry. The company focuses on the development and commercialization of technologies for peripheral nerve regeneration and repair. Its product offerings include the Avance Nerve Graft, Axoguard Nerve Connector, and Axoguard Nerve Protector, among others. Led by CEO Michael D. Dale, Axogen supplies its products to hospitals and various surgical centers worldwide.
Bottom Line
John Johnson's recent acquisition of Axogen shares highlights insider confidence in the company's potential. Investors track these transactions for insights into company performance and insider sentiment. Keep in mind that 13F filings and insider trades are often disclosed after the fact, so they may not reflect the current state of holdings.
Get Axogen, Inc. alerts
New 13F filings, insider trades, and analyst moves on $AXGN, sent to your inbox. Free, and you can unsubscribe anytime.
Related Filing Alerts
This instant news alert was generated by automated narrative technology and financial data from EarningsIQ and public regulatory filings. It is for informational purposes only and is not financial advice.